WMBIO 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
WM-S1 / WMBIO
NCT04801095: A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

Recruiting
1
100
RoW
WM-S1-030
Wellmarker Bio, Covance
Advanced Solid Tumor, Metastatic Solid Tumor, Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Cholangiocarcinoma, Head and Neck Cancer
08/25
08/25
WM-A1-3389 / WMBIO
KEYNOTE-E90, NCT05872867: Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/)

Recruiting
1
54
RoW
WM-A1-3389, Pembrolizumab, KEYTRUDA®
Wellmarker Bio, Merck Sharp & Dohme LLC
Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, Cholangiocarcinoma, Head and Neck Cancer, Non Small Cell Lung Cancer
02/26
02/26
WM-D2 / WMBIO
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
WM-S1 / WMBIO
NCT04801095: A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

Recruiting
1
100
RoW
WM-S1-030
Wellmarker Bio, Covance
Advanced Solid Tumor, Metastatic Solid Tumor, Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Cholangiocarcinoma, Head and Neck Cancer
08/25
08/25
WM-A1-3389 / WMBIO
KEYNOTE-E90, NCT05872867: Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/)

Recruiting
1
54
RoW
WM-A1-3389, Pembrolizumab, KEYTRUDA®
Wellmarker Bio, Merck Sharp & Dohme LLC
Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, Cholangiocarcinoma, Head and Neck Cancer, Non Small Cell Lung Cancer
02/26
02/26
WM-D2 / WMBIO
No trials found

Download Options